"Vidarabine Phosphate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adenosine monophosphate analog in which ribose is replaced by an arabinose moiety. It is the monophosphate ester of VIDARABINE with antiviral and possibly antineoplastic properties.
| Descriptor ID |
D001084
|
| MeSH Number(s) |
D03.633.100.759.646.138.925 D13.695.065.900 D13.695.667.138.925
|
| Concept/Terms |
Vidarabine Phosphate- Vidarabine Phosphate
- Phosphate, Vidarabine
- Arabinofuranosyladenine Monophosphate
- Monophosphate, Arabinofuranosyladenine
- Ara-AMP
- Ara AMP
- 9-(5-O-Phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine
- Adenine Arabinoside Monophosphate
- Monophosphate, Adenine Arabinoside
- Vidarabine Monophosphate
- Monophosphate, Vidarabine
|
Below are MeSH descriptors whose meaning is more general than "Vidarabine Phosphate".
Below are MeSH descriptors whose meaning is more specific than "Vidarabine Phosphate".
This graph shows the total number of publications written about "Vidarabine Phosphate" by people in this website by year, and whether "Vidarabine Phosphate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vidarabine Phosphate" by people in Profiles.
-
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes. Biol Blood Marrow Transplant. 2009 May; 15(5):610-7.
-
Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet. 2002; 41(2):93-103.
-
The role of c-Jun kinase in the apoptotic response to nucleoside analogue-induced DNA damage. Cancer Res. 2000 Nov 15; 60(22):6408-15.
-
Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia. Blood. 1998 Mar 01; 91(5):1742-8.
-
Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha: affinity, interaction, and consequences. Clin Cancer Res. 1997 Aug; 3(8):1347-55.
-
Why do drugs work in CLL? Leuk Lymphoma. 1996 Oct; 22 Suppl 2:1-11.
-
2Chlorodeoxyadenosine therapy of patients with Waldenstr?m macroglobulinemia previously treated with fludarabine. Ann Oncol. 1994 Mar; 5(3):288-9.
-
Fludarabine phosphate: a new active agent in hematologic malignancies. Semin Hematol. 1994 Jan; 31(1):28-39.
-
New initiatives with fludarabine monophosphate in hematologic malignancies. Semin Oncol. 1993 Oct; 20(5 Suppl 7):13-20.
-
2-Chlorodeoxyadenosine for multiple myeloma. Blood. 1993 Feb 01; 81(3):868-9.